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Abstract   
 
Background:  The role that vitamin D plays in numerous biological systems has been an intriguing 
topic in recent decades. Currently, scientists are researching its interaction with the central nervous 
system, and in particular, the ageing brain. Substantial data from animal research exist on the 
physiologic effects of vitamin D on the neurological system. It is postulated that this vitamin may 
influence cognitive function in humans.       
Methods:  Using the search terms “vitamin D” and “cognitive function,” an exhaustive literature 
search was performed using the following databases:  Medline-OVID, Web of Science, MD Consult, 
CINHAL, and PsycINFO. Any other scientific terms that can be used for these two terms were 
searched, as well, including but not limited to “cholecalciferol” and “cognition” and “cognitive 
decline” so that relevant research articles were not overlooked. Articles pertaining to the clinical 
question were then appraised and assigned a validity score.      
Results:  Five articles met the inclusion and exclusion criteria for the systematic review. All of the 
articles were observational studies. The results of three of them found a positive correlation between 
vitamin D levels and cognitive function, while the results of other studies did not reveal an association 
between the two variables.     
Conclusion:  The articles included in this study did not reach a collective agreement on an answer to 
the clinical question posed. Future research is warranted on this topic due to its potential impact on 
managing elderly medical care, and it should focus on the efficacy of using supplemental vitamin D to 
decrease risk of age-related cognitive decline. 
Keywords:  vitamin D, cognition 
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The Relationship Between Vitamin D Deficiency and Cognitive Decline in the  
Geriatric Population 
 
BACKGROUND 
 
Overview 
 Vitamin D has been under much scrutiny in recent decades for its effects on many biological 
systems. The earliest research studies addressed its actions in calcium homeostasis and bone formation. 
1,2 Currently, it is postulated that this vitamin may interact with the immune, cardiovascular, 
musculoskeletal, endocrine, and nervous systems. 1,3-6 New studies are exploring its interaction with 
the central nervous system and, in particular, the ageing brain. 6 Numerous studies have found vitamin 
D receptors (VDRs) in locations of the brain involved in cognition, such as the cortex, hypothalamus, 
and substantia nigra. 5-8 Also, metabolic pathways have been discovered in the cerebellum and 
hippocampus, suggesting vitamin D’s role in basic cognitive function, executive function, and 
formation of memories. 4,5 Robust data from in vitro and animal studies suggest that vitamin D has 
neuroprotective properties, indicating that it may contribute to the prevention of neurodegenerative 
disease in ageing individuals. 1,2,4,6,7,9-11 
Mechanism of Vitamin D 
 Vitamin D is a multipurpose, fat-soluble, seco-steroid hormone. 5,6,8The two most important 
forms of vitamin D are cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2). 1 The former is 
produced in the skin by sunlight, while the latter is contained in some fruits and vegetables and 
fortified foods. 1These forms of vitamin D are inactive until they are metabolized by the liver and 
kidney.1  Once biologically active, vitamin D binds to intracellular VDRs, such as those expressed on 
neurons. 1,8 It is the interaction with these VDRs that enables vitamin D to act on a cellular level. 12 
Serum 25(OH)D is the active metabolite of cholecalciferol and ergocalciferol that is usually measured 
to determine the Vitamin D status of an individual. 8  
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Prevalence of Vitamin D Deficiency 
 Hypovitaminosis D is prevalent among older adults 5,13 due to both low dietary intake and 
inadequate sun exposure. 6,13As many as fifty to eighty percent of elderly people have low vitamin D 
levels. 14 However, due to lack of screening, the proportion of the geriatric population that has 
unrecognized vitamin D deficiency may be much larger.  15 Those at highest risk for low vitamin D 
status include individuals with low sunlight exposure, females, those with poor nutrition, people who 
have dark pigmented skin, and the elderly.  3 There is some discrepancy about how much of the 
vitamin is enough. Vitamin D deficiency is defined by some as a 25(OH)D value less than 20ng/mL.16 
Some researchers further separate the categories into insufficiency (values less than 10ng/mL) , 
deficiency (values from 10-20mL), and  sufficiency (values greater than 20ng/mL). 4 Yet, others use a 
less lenient value to define deficiency (any value less than 25ng/mL). 17 
Dementia and Cognitive Decline 
 Dementia is defined as cognitive decline resulting in memory deterioration and impaired daily 
functioning4, and its development may involve several mechanisms. 10 Signs and symptoms of 
decreased cognition in persons of advanced age are connected to both biological and environmental 
factors. 18 By determining the role that vitamin D plays in these mechanisms, researchers have the 
capacity to improve overall health and decrease morbidity in the aging population. 
 The geriatric population is rapidly growing, and individuals eighty-five years old or older 
compose the group that is increasing the fastest. 4 Memory problems are reported by the majority of 
elderly patients. 18  It is known that memory is related to other cognitive abilities such as attention, 
executive control, learning, and problem-solving. 18 Deficits in these areas can be disabling and 
debilitating in these individuals. Studies have shown that there are higher mortality rates and increased 
risk of future nursing home admission in older adults with low vitamin D levels. 5,13 As the number of 
elderly patients increases, undoubtedly, the number of individuals with dementia and cognitive 
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dysfunction will rise. The impact that this may have on society would be immense, having the potential 
to drain health care resources and increase medical costs system-wide.       
Purpose of Study 
 The majority of evidence regarding the action of vitamin D in the central nervous system and 
its effects on cognitive function comes as a result of experiments performed on laboratory rats or mice. 
2 Evidence that vitamin D is involved in brain function is strong; however, studies measuring its 
impact on human cognition yield mixed results. 2 The purpose of this study is to conduct a systematic 
review of recent research articles regarding vitamin D and cognitive decline in the elderly population 
to determine if any correlation can be found between the two variables.   
Clinical Question and its Significance 
 Answering the question of whether or not vitamin D has an impact on cognitive function in the 
elderly is clinically relevant because it may impact how and when clinicians screen for vitamin D 
deficiencies and may propel future research in the direction of examining the efficacy of vitamin D 
supplementation for management or prevention of dementia in the geriatric population. 
METHODS 
Description of Search 
 An exhaustive literature search was performed using the following databases:  Medline-OVID, 
Web of Science, MD Consult, CINHAL, and PsycINFO. The search was executed using the following 
terms:  vitamin D, dementia, cognition, cognitive decline, and cognitive dysfunction. References from 
the bibliographies of articles found in the initial search were obtained and were also utilized. 
Eligibility Criteria 
 This systematic review included studies in which cognitive status or dementia was measured, 
serum 25(OH)D was a measured outcome, and an association between the two measurements was 
explored. Articles published after 2000 were included in the systematic review. All articles used were 
full-text and published in the English language. 
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Assessment of Validity 
 Articles that met the eligibility criteria were then critically appraised in order to evaluate their 
validity. A scoring system was created so that validity criteria could be used to assess the reliability of 
each of the articles. Figure I shows the validity scoring system used. Each article was assigned a 
numerical value based upon the number of criteria it met.       
Exclusion Criteria 
 Articles scoring 3/7 or less on the self-created validity scoring system were excluded from the 
formal review of literature. Articles were excluded if the study sample included participants less than 
sixty years of age. Other systematic reviews on this topic were excluded from the formal analysis of 
this systematic review of literature.  
RESULTS 
 Five studies met the inclusion/exclusion criteria mentioned in the methods section. All five 
studies were observational studies, and were able to be compared to each other when necessary. Three 
of these studies showed a positive association between cognitive function and vitamin D status. On the 
other hand, two of the research articles found there was no association between the two variables.  
Summary of Studies 
  25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home 
services 21 (2010) was a retrospective chart review of four years of data collected between 2003 and 
2007. The study used urban-dwelling subjects who partook in homecare services. Participants in this 
study were low income, had diminished ability to perform activities of daily living (ADLs), and had 
unmet needs such as food or personal care. There were 305 subjects who were evaluated for vitamin D 
deficiency and cognitive decline. Subjects were assigned diagnoses of dementia or no cognitive decline 
using criteria from the National Institute of Neurological and Communicative Disorders, Stroke-
Alzheimer’s Disease and Related Disorders Association, and DSM-IV. Magnetic Resonance Imaging 
(MRI) of the brain was performed on each of the subjects. Logistic regression models were used to 
 11 
evaluate the associations between vitamin D levels and diagnoses of Alzheimer’s disease (AD), all-
cause dementia, and stroke. Adjustments in analysis were made for covariates such as age, BMI, 
plasma homocysteine, physical activity, gender, ethnicity, education level, ApoE allele status, diabetes, 
hypertension, and multivitamin use. The results revealed that 25(OH)D insufficiency (<20ng/mL) was 
associated with more than two times the risk of all-cause dementia and AD after all adjustments were 
made.  
 Higher serum vitamin D3 levels are associated with better cognitive test performance in 
patients with Alzheimer’s disease 8 (2008) was a cross-sectional observation study. It chose its sample 
population from a group of 962 patients referred to a geriatric outpatient clinic. Of these patients, 225 
were diagnosed with probable AD and underwent laboratory testing for vitamin D levels. Patients were 
excluded for taking any vitamin supplementation at the time of investigation. Dementia and AD was 
diagnosed according to DSM-IV and NINCDS-ADRDA criteria, respectively. Patients were placed 
into vitamin D categories. Vitamin D-sufficient subjects had >20ng/mL serum 25(OH)D levels, while 
vitamin D-insufficient and deficient subjects had 10-19.9ng/mL and <10ng/mL, respectively. Linear 
regression models were utilized to determine relationships between MMSE score and vitamin D levels. 
Analysis showed positive association between serum 25(OH)D levels and MMSE score (p <0.001).  
After adjusting for cofactors such as sunlight exposure and educational background, the association 
remained statistically significant (p=0.01). 
 Vitamin D is associated with cognitive function in elders receiving home health services 4 
(2009) was a cross-sectional retrospective chart review that selected subjects from the same population 
that was used for the 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders 
receiving home services 21 article mentioned above. The study sample for this paper, however, was 
much larger.  Its sample size was 1,080. Another difference between this study and the other was that 
subjects underwent a neuropsychological battery of tests by trained research assistants which included 
testing verbal intelligence, auditory and visual retention, executive function, mental processing speed, 
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visual construction, fluid reasoning, and verbal fluency. Univariate and multiple regression models 
were constructed to look at associations of serum 25(OH)D concentration and cognitive function. The 
authors found significant associations between vitamin D concentration and the executive function, 
attention, and processing speed factors, even after covariate adjustment (p<0.01). Low vitamin D 
levels were associated with impairments in cognitive function, mostly in areas of executive functioning 
(planning for the future, problem solving, or sequencing) and processing speed. However, no 
relationship was noted between memory and vitamin D levels.  
 Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer’s disease 17 
(2009) was a case-controlled observational study which found no correlation between vitamin D and 
AD. Subjects for this article were recruited from an outpatient clinic and assigned to groups based 
upon diagnosis of mild cognitive impairment, mild AD, and cognitively normal controls. Diagnoses 
were made by a psychiatrist, psychologist, and radiologist based upon the results of the following 
examinations:  comprehensive psychometric testing, CT or MRI brain imaging, extensive blood 
screening, physical examination, and detailed medical history. The sample size was 47 (19 in the mild 
cognitive impairment group, 20 in the AD group, and 8 in the cognitively normal group). A large 
battery of tests was used to assess cognitive levels in the subjects. This battery included but was not 
limited to MMSE, Clockdrawing Test, Trail Making Test, Global Deterioration Scale, and Clinical 
Dementia Rating Scale. Two-sided t tests were used for all primary group comparisons of biochemical 
data. Two-sided Pearson correlation analyses were calculated for age and biochemical markers and 
MMSE scores. No statistically significant difference was discovered between the vitamin D levels of 
the controls versus those of the AD and mild cognitive impairment groups.  
 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men 16 (2009) 
was unique in that it was a prospective cohort study which explored the temporal relationship between 
the two variables to see if fluctuations in vitamin D in an individual correlated with variations in the 
individual’s cognitive function. The sample population was composed of 1,138 community-dwelling 
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male subjects who were recruited from several different urban cities in the United States. The subjects 
were included in a prospective analysis of follow-up on cognitive decline. Cognitive function was 
assessed by a trained technician with the 3MS and Trails B tests at baseline and at the follow-up 
examination. Logistical regression models were used to examine the relationship between baseline 
25(OH)D level and odds of cognitive impairment and decline. Serum 25(OH)D was expressed in 
various ways. It was expressed in quartiles, as a dichotomous variable, and as a continuous variable. 
Analyses were adjusted for age, clinic site, season of blood draw, ethnicity, education, age, self-
reported health status, ADL impairments, smoking, alcohol consumption, BMI, and physical activity 
level. Before adjusting for the cofactors, men with lower vitamin D levels had increased odds of 
cognitive impairment at baseline. After adjusting for education level and ethnicity, there were no 
statistically significant associations between vitamin D and cognitive levels. In models adjusted for 
age, season, and study site, there was an association between lower vitamin D levels and odds of 
cognitive decline as defined by only one of the cognitive measures, the 3MS (p=0.04). After further 
adjusting the models for ethnicity and education level, the association was decreased to the point that it 
was not statistically significant.  
DISCUSSION 
 The purpose of this paper was to explore the association between vitamin D and cognition in 
the elderly. Five articles from 2000-2010 met the inclusion/exclusion criteria of this systematic review. 
The articles included in this study did not reach a collective agreement on an answer to the clinical 
question posed.   
 Even though all five studies were observational, they had differing designs. For example, two 
of the studies were case-controlled. These studies had the ability to compare vitamin D levels between 
those with and without cognitive dysfunction, allowing prediction of an odds ratio or relative risk. Four 
of the five studies made adjustments in their statistical analyses for covariates. Adjusting for 
confounding factors limits outcome bias by accounting for participant characteristics that may affect 
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one of the outcomes being measured. Only one study was longitudinal, exploring the temporal 
relationship between vitamin D levels and cognitive function. 
Limitations of Study 
 Each study had its own inherent limitations.  In 25-Hydroxyvitamin D, dementia, and 
cerebrovascular pathology in elders receiving home services 21 (2010), the limitations of the study 
were that it was a cross-sectional study, so no temporal relationships between the two variables were 
explored. Also, participants were recruited from social services, so they cannot be generalized to a 
community-dwelling population. Lastly, no control group was used for comparison. The study entitled 
Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with 
Alzheimer’s disease 8 (2008) was unable to assess if cognitive levels fluctuated with changes in 
vitamin D status over time, and it did not compare the study group to a control group. Of most concern 
is that this study used only one measure of cognitive function (the MMSE) to assess the relationship 
between cognition and vitamin D status. Vitamin D is associated with cognitive function in elders 
receiving home health services 4 (2009) had similar limitations to the ones described above. The 
sample is not representative of the general population. No temporal relationships can be deciphered 
from the data, and again, no case controls were utilized. The main limitation of Blood biomarkers of 
osteoporosis in mild cognitive impairment and Alzheimer’s disease 17 (2009) was the very small 
sample size, which decreased the chance that findings would be statistically significant. Another 
limitation was that linear regression models were not used to evaluate the relationship between levels 
of vitamin D and levels of cognition. This study, unlike the others, did not make adjustments in its 
analysis to account for covariates that may have affected the outcomes. Yet another problem was that 
similar to the other studies in this review, this was not a longitudinal study, so no inferences can be 
made upon the temporal relationship between vitamin D and cognition. The problems of the study, 25-
Hydroxyvitamin D levels and cognitive performance and decline in elderly men 16 (2009) were three-
fold. The sample was all male and mostly white and is not generalizable to the elderly population. 
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Participants who did not follow-up for the prospective portion of the study tended to be older, frailer, 
and had lower baseline vitamin D levels and lower baseline cognitive function than those who did 
follow-up. This may have skewed the prospective results. Lastly, a relatively small battery of tests was 
utilized to assess cognition. 
 One feature that all the studies shared was that they were observational studies. Although this 
makes it easier to compare and contrast the studies with one another, the lower validity of 
observational studies must be taken into consideration. Because observational studies are per se less 
valid than randomized controlled trials (RCTs), bias, confounding, and chance must be thoroughly 
assessed in each study. 19 
 Other reasons for the discrepancies between the studies’ results can be estimated by examining 
the variations in sample populations, outcome measurements, and methodology between the five 
studies. The observational design of these studies did not allow any randomization in the sample 
populations, which made it difficult to compare and contrast between the studies and, thus, limited the 
ability to apply the results to the general geriatric population. Also the sample sizes of the studies were 
not impressively large. In fact, one of the studies in this review had fewer than 100 participants, 
although the study fit this systematic review’s inclusion/ exclusion criteria. Statistically significant 
results are a challenge to obtain with such a small sample. 
 Although serum 25(OH)D measurement methods were uniform among the studies, the 
measurement of cognitive function, cognitive decline, and dementia were vastly inconsistent. Each 
study used different quantities and types of assessments to measure cognition as an outcome. This 
poses a constraint on making comparisons between studies. 
Recommendations for Future Studies 
 In order to answer the clinical question as to whether or not an association exists between 
cognitive function and vitamin D levels in geriatric patients, more research is warranted. This research 
should utilize randomized controlled trials to increase the validity of the results. Another suggestion is 
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that future study analyses should adjust for confounding variables to limit characteristics that may 
independently contribute to the outcome of interest. Future studies would also benefit from using some 
standardized outcome measurement of cognition. Maybe researchers could determine the most 
effective and accurate manner of quantifying cognitive levels in the elderly. Some sort of consistent 
protocol could help to consolidate results among various research studies and aid in the interpretation 
of the results.  
 Another way that this clinical question can be addressed is to assess whether or not vitamin D 
supplementation protects against cognitive decline in the elderly. This could be undertaken by 
designing placebo-controlled interventional studies. Additionally, long prospective cohort studies 
could be utilized to determine if correction of vitamin D deficiency in the elderly could prevent 
cognitive decline in this population.  
CONCLUSION 
 
 Although there is substantial data on the physiologic effects of vitamin D on the central 
nervous system as demonstrated by research on animals, there is not sufficient data on humans to 
conclude a correlation between this vitamin and cognitive function. Furthermore, too few studies of 
high validity have been performed on the geriatric population to discern a relationship between age-
related cognitive decline and vitamin D levels. Future research is warranted on this topic due to its 
potential impact on managing elderly medical care. In particular, future research should focus on the 
efficacy of using supplemental vitamin D to decrease the risk of age-related cognitive decline, thus 
reducing overall morbidity in this continually growing age group.  
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TABLES 
 
Table I.  Summary of Critically Appraised Articles 
 
Author/ 
Year 
Study type Population 
 
Comparison Outcome(s) Validity 
Score 
Przybleski 
et al 20 
(2006). 
Retrospective 
chart review 
32 patients age >60 
that had been referred 
for assessment of 
memory loss behavior 
problems associated 
with cognitive 
impairment. 
None Serum Vit D. concentration and 
Mini Mental Status Exam 
(MMSE) showed a significant 
positive correlation (p=0.006). 
1 
Wilkins et 
al 15  
(2006). 
Cross-
sectional 
observational 
study 
40 patients with mild 
AD age > 60. 
40 patients 
with no 
dementia. 
Vitamin D deficiency was 
associated with impairment on 2 
of 4 measures of cognitive 
performance.   
3 
McGrath 
et al 11 
(2007). 
Retrospective 
observation 
of a survey 
3 groups: 1,676 
adolescents (age 12-
16), 4,747 adults (age 
20-59), 4,808 elderly 
(age 60-90). 
None. In elderly group, those with the 
highest Vitamin D levels 
demonstrated the most 
impairment on the memory task.  
In the adolescent and adult group, 
there was no association between 
performance and vitamin D 
levels.  
3 
Oudshoor
n et al 
8(2008). 
Cross-
sectional 
observational 
study 
225 outpatients with 
diagnoses of probable 
AD age >60. 
 
 
None.  Vitamin D-sufficient patients had 
significantly higher MMSE 
scores as compared to vitamin-D-
insufficient ones.   
4 
Luckhaus 
et al 17 
(2009). 
Cross-
sectional 
observational 
study 
3 groups: 19 patients 
with mild cognitive 
impairment, 7 with 
primary osteoporosis, 
20 with AD. 
8 
cognitively 
normal 
age-
matched 
controls 
Vitamin D levels were of equal 
amounts in the control group, 
mild cognitive impairment group, 
and Alzheimer’s dementia group.   
5 
Buell et al 
21 (2010). 
Cross-
sectional 
observational 
study 
4 groups totaling 318.  
41 with AD, 22 stroke 
with dementia, 76 all-
cause dementia. 
211 no 
stroke or 
dementia. 
Mean vitamin D concentrations 
were lower in subjects with 
dementia 
4 
Buell et al 
4 (2009). 
Cross-
sectional 
observational 
study 
1,080 elders > age 65. None. Vitamin D was associated with 
executive function and attention 
and processing speed factors, but 
not the memory factor.   
4 
Slinin et al 
16 (2009). 
Prospective 
cohort study 
1,376 community-
dwelling men age >65. 
None After adjusting for covariates, 
there was no association between 
vitamin D level and cognitive 
impairment by 3MS testing or the 
Trails B test.   
4 
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Table II. Summary of Reviewed Articles 
 
 Study Name Outcome(s) Validity 
Score 
Positive 
Correlation 
Oudshoorn et al. Higher serum 
vitamin D3 levels are associated 
with better cognitive test 
performance in patients with 
Alzheimer’s disease 8 (2008). 
Vitamin D-sufficient patients had 
significantly higher MMSE scores 
as compared to vitamin-D-
insufficient ones.   
4 
Buell et al. 25-Hydroxyvitamin D, 
dementia, and cerebrovascular 
pathology in elders receiving home 
services 21 (2010). 
Mean vitamin D concentrations 
were lower in subjects with 
dementia 
4 
Buell et al. Vitamin D is associated 
with cognitive function in elders 
receiving home health services 4 
(2009). 
Vitamin D was associated with 
executive function and attention 
and processing speed factors, but 
not the memory factor.   
4 
No 
Correlation 
Luckhaus et al. Blood biomarkers of 
osteoporosis in mild cognitive 
impairment and Alzheimer’s disease 
17 (2009). 
Vitamin D levels were of equal 
amounts in the control group, mild 
cognitive impairment group, and 
Alzheimer’s dementia group.   
5 
Slinin et al. 25-Hydroxyvitamin D 
levels and cognitive performance 
and decline in elderly men 16 (2010). 
After adjusting for covariates, there 
was no association between vitamin 
D level and cognitive impairment 
by 3MS testing or the Trails B test.   
4 
 
 
Table III.  Validity Scoring System 
 
Validity Criteria Numerical Value 
Sample size > 100. 1 
Control or comparison group was utilized. 1 
Control group was age-matched. 1 
>1 cognitive test was used to diagnose dementia. 1 
Stage or severity of dementia was described. 1 
Adjustments for cofactors were made in statistical analysis. 1 
Study was longitudinal. 1 
Total Score (out of 7)  ____ 
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Table IV.  Summary of Cognitive Assessments 
 
Test Name Description 
Mini Mental Status Exam  
(MMSE) 
Tool commonly used to measure five areas of cognitive function. It 
asses orientation, registration, attention and calculation, recall, and 
language. The maximum score is 30, with a score of 23 or less 
indicating cognitive impairment. It takes 5-10 minutes to 
administer. 22 
Short Blessed Test (SBT) Initial screening test that is sensitive to early changes associated 
with Alzheimer’s disease. Higher scores are suggestive of 
impairment consistent with dementia, and an additional cognitive 
assessment is recommended. Scores in the normal range suggest 
that a dementing disorder is unlikely.  23 
Clinical Dementia Rating 
(CDR) 
Rates cognitive performance in each of six categories: memory, 
orientation, judgment and problem-solving, community affairs, 
home management and hobbies, and personal care. CDR of zero 
indicates no dementia, while a CDR of 3 indicates severe dementia. 
15 
CDR Sum of Boxes 
Score 
Summation of the individual scores in the six CDR categories.  
Ranges from zero to eighteen. 24  
3MS Test of global cognitive function, with scores ranging from zero to 
100. Higher scores represent greater cognitive function. 16 
Trails B Test of executive function, assessing “attention, concentration, 
psychomotor speed, cognitive shifting, and complex sequencing 
function by measuring the time required to connect a series of 
sequentially numbered and lettered circles”. Test score is affected 
by age, education, and general intelligence. Outcomes measured in 
times; shorter times indicating better executive function. 16 
 
 
 
 
 
 
 
 
 
